Asensus Surgical Stock (NYSEAMERICAN:TRXC)


$ -
52-Week Range
$ - $
Market Cap

About Asensus Surgical (NYSEAMERICAN:TRXC)

(NYSEAMERICAN:TRXC) Asensus Surgical, Inc. engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. It digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through a new category of care called Digital Laparoscopy. The company's digital interface enables the use of capabilities, such as augmented intelligence, connectivity, and robotics in laparoscopy, as well as allows to address the current clinical, cognitive, and economic shortcomings in surgery. The company's products include Senhance Surgical System, a multi-port robotic surgery system that allows multiple robotic arms to control instruments and a camera; and SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform. It offers its products directly and through distributors in Europe, the United States, Japan, Taiwan, and internationally. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. was founded in 2006 and is based in Morrisville, North Carolina.
Show more

TRXC Stock Price

Statistics Highlights (NYSEAMERICAN:TRXC)

Shares Outstanding 224.73M Beta 1.98
Public Float 98.12M P/E Ratio -
% Short of Float - Dividend (Yield) -
Held by Insiders 4.05% Ex-Dividend Date
Held by Institutions 25.15% IPO Date Nov 12, 1992

TRXC Financial Summary

Dec 20 Dec 19 Dec 18
Revenue $3.17M $8.53M $24.10M
EBITDA $-45.81M $-81.44M $-53.48M
Net Income $-59.31M $-154.20M $-61.78M
Total Assets $78.26M $74.78M $239.31M
Total Cash $16.36M $9.60M $21.06M
Total Debt $2.81M $1.11M $80.73M
Mar 21 Dec 20 Sep 20
Revenue $2.08M $1.11M $814.00K
EBITDA $ $-8.84M $-11.03M
Net Income $-17.34M $-13.79M $-15.08M
Total Assets $223.62M $78.26M $80.14M
Total Cash $165.25M $16.36M $19.96M
Total Debt $ $2.81M $2.81M

TRXC Stock Price History

Asensus Surgical Annual Stock Price History

Year Open Close Change
2020 $1.40 $0.65 -53.57%


What is Asensus Surgical's 52-week change?

  • Asensus Surgical share price volatility (52-week beta) is 1.98.

Is Asensus Surgical a buy?

  • According to 2 analysts, the current consensus recommendation for Asensus Surgical stock is "Buy" at an average rating score of 4.00 (out of 5).
  • There are currently 1 "Strong Buy", 0 "Buy", 1 "Hold", 0 "Sell", and 0 "Strong Sell" analysts recommendations for the TRXC stock.


How Much is Asensus surgical Worth?

Asensus surgical's worth today based on market capitalisation is $916.88M

How much dividend does Asensus surgical Pay?

The current annualized dividend payout for TRXC stock is $0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Asensus surgical's "Dividend" Section

What is Asensus surgical’s Price to Earning (PE) ratio?

TRXC stock also has a Price to Sales (P/S) ratio of 92.87, a Price to Book of 18.58 and Price/Earnings to Growth (PEG) of 0.00.

What is the Asensus surgical's ticker?

Asensus surgical trades on the NYSE American stock market in USA under the ticker symbol "TRXC". Asensus surgical’s stock symbol can also be displayed as "NYSEAMERICAN:TRXC".

When did TRXC go public?

Asensus surgical completed its initial public offering (IPO) on November 12 ,1992.

Who are the owners of Asensus surgical?

Asensus surgical (NYSEAMERICAN:TRXC) is owned by 25.15% institutional shareholders and by 4.05% insiders. The rest is owned by the public.
Explore More Details on Asensus surgical's “Ownership” Section

Who are the key executives of Asensus surgical (TRXC)?

Asensus surgical's key executive team includes the following managers:

  • Mr. Anthony Fernando, Pres, CEO & Director (1972)
  • Mr. Todd M. Pope, Sr. Advisor (1965)
  • Mr. Shameze Rampertab B.Sc. MBA, CA, CPA, Exec. VP & CFO (1967)
  • Mr. Joshua B. Weingard, Chief Legal Officer & Sec. (1973)
  • Mr. Paul Ziegler, VP of Sales (NA)
  • Ms. Amanda Owens, Global Head of People (NA)
  • Dr. Stephanie M. Fitts, VP of Clinical, Quality and Regulatory Affairs (1966)

What is Asensus surgical’s Sector & Industry Classification?

Asensus surgical (NYSEAMERICAN:TRXC) is classified under the "Healthcare" sector and under the "Medical Devices" industry.

How many employees work for Asensus surgical?

Currently the number of employees working for Asensus surgical is 160.

Where are Asensus surgical's Headquarters?

Asensus surgical (NYSEAMERICAN:TRXC) is headquartered in NC, United States.

What are Asensus surgical's Address and Phone Number?

Asensus surgical’s mailing address is 635 Davis Drive, Morrisville, NC, United States, 27560.
The company’s phone number is 919 765 8400.

What is the official website for Asensus surgical?

Asensus surgical’s official website is